SMAD3 and Alzheimer disease: The majority of vascular transcriptional changes occur in pericytes, with SMAD3 upregulated in Alzheimer’s disease pericytes having the highest number of ligands including VEGFA, which is downregulated in Alzheimer’s disease astrocytes [74].